(0.09%) 5 251.00 points
(0.07%) 39 668 points
(0.15%) 18 282 points
(0.32%) $78.51
(1.82%) $2.29
(-0.83%) $2 355.20
(-0.42%) $28.39
(0.15%) $1 008.70
(-0.06%) $0.928
(0.21%) $10.86
(0.00%) $0.798
(-0.94%) $91.80
Live Chart Being Loaded With Signals
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors...
Stats | |
---|---|
Today's Volume | 252 267 |
Average Volume | 777 566 |
Market Cap | 43.00M |
EPS | $-487.15 ( 2024-05-09 ) |
Next earnings date | ( $-0.470 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.780 |
ATR14 | $0.00600 (0.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Cormorant Asset Management, Lp | Sell | 100 | Class A Common Stock |
2024-04-01 | Cormorant Asset Management, Lp | Sell | 300 | Class A Common Stock |
2024-04-01 | Cormorant Asset Management, Lp | Sell | 100 | Class A Common Stock |
2024-04-01 | Cormorant Asset Management, Lp | Sell | 600 | Class A Common Stock |
2024-04-01 | Cormorant Asset Management, Lp | Sell | 10 | Class A Common Stock |
INSIDER POWER |
---|
6.04 |
Last 92 transactions |
Buy: 3 241 516 | Sell: 1 367 921 |
Volume Correlation
Immuneering Corporation Correlation
10 Most Positive Correlations | |
---|---|
CPSH | 0.958 |
RGF | 0.956 |
PHCF | 0.955 |
PAIC | 0.952 |
WKSP | 0.95 |
SVAC | 0.945 |
PRTS | 0.942 |
JRJC | 0.942 |
TIL | 0.941 |
BLPH | 0.933 |
10 Most Negative Correlations | |
---|---|
NETE | -0.972 |
GRCL | -0.959 |
MMAC | -0.953 |
VITL | -0.951 |
SASR | -0.949 |
MNMD | -0.947 |
MIRO | -0.945 |
DXPE | -0.943 |
BSRR | -0.942 |
GIFI | -0.942 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immuneering Corporation Correlation - Currency/Commodity
Immuneering Corporation Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-764 138 (0.00 %) |
EPS: | $-1.880 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-764 138 (0.00 %) |
EPS: | $-1.880 |
FY | 2022 |
Revenue: | $316 952 |
Gross Profit: | $158 830 (50.11 %) |
EPS: | $-1.870 |
FY | 2021 |
Revenue: | $2.08M |
Gross Profit: | $927 000 (44.57 %) |
EPS: | $-2.46 |
Financial Reports:
No articles found.
Immuneering Corporation
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators